Emblem (EMMBF) Stock Price, News & Analysis

Company Overview

Emblem Corp is a Canadian licensed producer of medical cannabis headquartered in Montreal, Quebec. The company operates a purpose-built greenhouse cultivation facility in Saint-Jean-sur-Richelieu, Quebec, along with extraction and product development laboratories. Emblem’s integrated platform covers every stage of the supply chain, from genetics research and cultivation to processing, quality assurance and fulfillment.

Emblem offers a range of cannabis products tailored to medical patients, including dried flower, oils, oral capsules and custom formulations. Its product portfolio is designed to address various patient needs, leveraging a genetics program that focuses on cannabinoid and terpene profiles. The company has also established a clinical research partnership with McGill University to investigate novel delivery formats and to expand the scientific understanding of cannabis-based therapies.

Emblem serves patients across Canada through provincial medical channels, with distribution in Ontario, Quebec and the Atlantic provinces. In Ontario and New Brunswick, the company operates branded medical cannabis dispensaries under its Ethnos retail banner. Emblem continues to explore opportunities in regulated international markets and to expand its footprint in Canada’s evolving adult-use and medical cannabis sectors.

Key Stats

• Today's Range: $1.36 to $1.45
• 50-Day Range: $1.40 to $1.40
• 52-Week Range: $0.60 to $1.63
• Volume: 156,200 shs
• Average Volume: 280,719 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

EMMBF Stock Analysis - Frequently Asked Questions

How have EMMBF shares performed this year?

Emblem's stock was trading at $1.40 at the beginning of 2025. Since then, EMMBF stock has increased by 0.0% and is now trading at $1.40.

How do I buy shares of Emblem?

Shares of EMMBF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Biotechnology
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:EMMBF
• CIK: N/A
• Web: emblemcorp.com
• Phone: (416) 962-3300
• Fax: N/A
• Employees: 74
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A